Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503438 · ClinicalTrials.gov registry record
Ankle Joint Replacement Outcomes Study
A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Smith & Nephew.
- Completed
- Registry status
- 76
- Enrollment target
- 2
- Study locations
NCT00503438: Completed study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Smith & Nephew.
NCT00503438 is a study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by Smith & Nephew. The registered enrollment target is 76 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00503438, a study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 2
- Study locations
Study Summary
This post market outcome study will look at the therapeutic results of the Salto Talaris Anatomic ankle prosthesis. The study population will consist of patients who will undergo an ankle arthroplasty procedure with a Salto Talaris ankle implant. An analysis will be conducted of the results, complications and revisions of this prosthesis based on the etiology for which the ankle arthroplasty was performed.
Primary Outcome
Count of participants without a failed ankle arthroplasty. Ankle arthroplasty will be considered as failed if the implant is revised or removed and the ankle fused.
Conditions Studied
Interventions
- DEVICE Salto Talaris Ankle
Study Locations (2)
Texas
- Foot and Ankle Center of South Texas - San Antonio
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2007-10-31 |
| Est. Completion | 2023-04-21 |
What the finished NCT00503438 record still lists
NCT00503438 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Salto Talaris Ankle is the first listed.
NCT00503438 reports a single indexed study location in Texas, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00503438 about?
NCT00503438 is a clinical study titled "Ankle Joint Replacement Outcomes Study". This post market outcome study will look at the therapeutic results of the Salto Talaris Anatomic ankle prosthesis. The study population will consist of patients who will undergo an ankle arthroplasty procedure with a Salto Talaris ankle implant. An analysis will be conducted of the results, complic...
What is the current status of trial NCT00503438?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2007-10-31. Estimated completion is 2023-04-21.
What conditions does trial NCT00503438 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Post Traumatic Arthritis, Septic Arthritis, Prior Ankle Fusion.
What interventions are being tested in trial NCT00503438?
The interventions under investigation include: Salto Talaris Ankle (DEVICE).
Who is sponsoring clinical trial NCT00503438?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00503438 being conducted?
This trial has 2 study locations across Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00503438's enrollment target sits among peer trials
76 125th of 197 higher than 73 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI